m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis. | Synapse
March 1, 2026Open Access
m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis.
Key Points
The central aim is to explore the predictive and therapeutic potential of m5C in nonalcoholic steatohepatitis (NASH).
Deciphering the role of m5C in NASH
Examining its predictive and therapeutic applications
Assessing personalized medicine approaches for NASH patients
Identified m5C as a novel diagnostic target
Demonstrated therapeutic potential of m5C in NASH
Enhanced understanding of personalized medicine applications for NASH patients
Abstract
Our study first deciphered the m5C in predictive and therapeutic potential for NASH patients, which gains more insight into their personalized and precision medicine.